Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Policy / Pricing
  • RFK Jr. defends HHS tenure, 12% proposed budget cut
  • Policy / Pricing

RFK Jr. defends HHS tenure, 12% proposed budget cut

BioPharma Dive

Republicans largely praised the HHS secretary s track record during a marathon of House hearings last week, but some raised concerns about proposed budget cuts to the National Institutes of Health.

Policy / PricingRead full story

pharminent April 20, 2026 (Last updated: April 21, 2026)

BioPharma Dive

Republicans largely praised the HHS secretary s track record during a marathon of House hearings last week, but some raised concerns about proposed budget cuts to the National Institutes of Health.

Policy / PricingRead full story

Post navigation

Previous: Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout
Next: Trump executive order lifts psychedelics biotechs

Related Stories

  • Policy / Pricing

Mid-cap biotechs join Trump’s latest round of drug pricing deals

pharminent September 1, 2026
  • Policy / Pricing

MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones

pharminent August 27, 2026
  • Policy / Pricing

MFN affecting Swiss medicines access, says Interpharma

pharminent August 13, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.